Clinical Trial Update: Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating methylene blue versus a vasopressin analogue for treatment of septic shock in preterm neonates; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis
• Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)
• Vasopressin analogue

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Sepsis, Refractory Shock | Phase 2 | Status: UNKNOWN